Semergen
Recommendations for the management of menopausal vasomotor symptoms in clinical practice
Abstract
These recommendations from the Spanish Association for the Study of Menopause offer a practical and up-to-date tool for healthcare professionals who treat middle-aged women with vasomotor symptoms. Based on a comprehensive review of clinical guidelines and scientific literature published over the last 15 years, they incorporate the latest advances in the management of hot flashes and night sweats. The document guides clinical evaluation and shared decision-making, considering individual factors that influence therapeutic choice. In addition to Hormone Therapy for Menopause, scientifically supported non-hormonal alternatives are included, among them fexofenadine, which has demonstrated efficacy in clinical trials for the treatment of moderate to severe vasomotor symptoms. Taken together, these recommendations constitute an accessible and up-to-date resource for improving the care and quality of life of women in the menopausal stage.
Source and rights
Published by Semergen, 2025. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2025
- Applies to
- 🇪🇸 Spain
- Scope
- National
- Journal
- Semergen
- PubMed




